BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7571)

  • 21. Bovine posterior pituitary extract stimulates prolactin release from the anterior pituitary gland in vitro and in vivo in cattle.
    Hashizume T; Sasaki T; Nonaka S; Hayashi T; Takisawa M; Horiuchi M; Hirata T; Kasuya E
    Reprod Domest Anim; 2005 Apr; 40(2):184-9. PubMed ID: 15819972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prolactin and the function of the central nervous system].
    Wieniawska-Szewczyk E; Szukalski B
    Psychiatr Pol; 1985; 19(6):466-73. PubMed ID: 2874576
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
    Barbarino A; De Marinis L; Maira G; Menini E; Anile C
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone.
    Snyder PJ; Jacobs LS; Utiger RD; Daughaday WH
    J Clin Invest; 1973 Sep; 52(9):2324-9. PubMed ID: 4199418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical application of TRH and metoclopramide (MCP) stimulating tests for prolactin].
    Lu YR
    Zhonghua Nei Ke Za Zhi; 1983 Oct; 22(10):598-601. PubMed ID: 6425022
    [No Abstract]   [Full Text] [Related]  

  • 26. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
    Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
    Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum prolactin during pregnancy induced by pituitary gonadotrophins in a patient with post partum hypopituitarism (Sheehan syndrome).
    Lee D; León C; Milanés BA
    Arch Invest Med (Mex); 1981; 12(1):29-41. PubMed ID: 6788010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progesterone inhibits prolactin and growth hormone release from fowl pituitary glands in vitro.
    Hall TR; Harvey S; Chadwick A
    Br Poult Sci; 1984 Oct; 25(4):555-9. PubMed ID: 6440662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metoclopramide stimulates prolactin secretion in man.
    McCallum RW; Sowers JR; Hershman JM; Sturdevant RA
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1148-52. PubMed ID: 777023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation of prolactin response to thyrotropin-releasing hormone and metoclopramide in chronic renal failure.
    Leroith D; Danovitz G; Trestan S; Spitz IM
    J Clin Endocrinol Metab; 1979 Dec; 49(6):815-7. PubMed ID: 117018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased prolactin and thyrotrophin secretion following oral metoclopramide: dose-response relationships.
    Healy DL; Burger HG
    Clin Endocrinol (Oxf); 1977 Sep; 7(3):195-201. PubMed ID: 908151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional evaluation of prolactin secretion: a guide to therapy.
    Friesen H; Guyda H; Hwang P; Tyson JE; Barbeau A
    J Clin Invest; 1972 Mar; 51(3):706-9. PubMed ID: 4622109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tests of prolactin secretion in diagnosis of prolactinomas.
    Cowden EA; Ratcliffe JG; Thomson JA; Macpherson P; Doyle D; Teasdale GM
    Lancet; 1979 Jun; 1(8127):1155-8. PubMed ID: 86882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
    Larson GH; Koos RD; Sortino MA; Wise PM
    Endocrinology; 1990 Feb; 126(2):927-32. PubMed ID: 2105207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stress- as well as suckling-induced prolactin release is blocked by a structural analogue of the putative hypophysiotrophic prolactin-releasing factor, salsolinol.
    Bodnár I; Mravec B; Kubovcakova L; Tóth EB; Fülöp F; Fekete MI; Kvetnansky R; Nagy GM
    J Neuroendocrinol; 2004 Mar; 16(3):208-13. PubMed ID: 15049851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The participation of hypothalamic dopamine in morphine-induced prolactin release in man.
    Delitala G; Grossman A; Besser GM
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):437-44. PubMed ID: 6627697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of prolactin and growth hormone secretion. Site and mechanism of action of thyrotropin-releasing hormone, L-dopa and L-5-hydroxytryptophan in unanesthetized dogs.
    Richards GE; Holland FJ; Aubert ML; Ganong WF; Kaplan SL; Grumbach MM
    Neuroendocrinology; 1980; 30(3):139-43. PubMed ID: 6767993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.